Join
Live feed
·
INSIDERFilingvia Quantisnow
Travere Therapeutics Inc. logo

CHIEF FINANCIAL OFFICER Cline Christopher R. was granted 28,130 shares and sold $232,613 worth of shares (7,242 units at $32.12), increasing direct ownership by 23% to 112,971 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TVTX· Travere Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVTX (Travere Therapeutics Inc.) and more on Quantisnow.

CHIEF FINANCIAL OFFICER Cline Christopher R. was granted 28,130 shares and sold $232,613 worth of shares (7,242 units at $32.12), increasing direct ownership by 23% to 112,971 units (SEC Form 4) | Quantisnow